Mbuvi Christine Musungi, Musila Boniface Nzioki, Nyamache Anthony Kebira
Dept of Population, Reproductive Health & Community Resource Management, Kenyatta University.
Dept of Obstetrics & Gynecology, Kenyatta University.
East Afr Health Res J. 2024;8(1):99-105. doi: 10.24248/eahrj.v8i1.754. Epub 2024 Mar 28.
Urogenital infections pose a considerable public health threat, as almost half of women will experience urinary and reproductive system infections at some point in their lives. However, the urogenital infection burden is often not clear in some regions. Nevertheless, the misuse of antimicrobial agents, including self-prescription, has increased widespread antimicrobial resistance, limiting treatment benefits. Therefore, this study aimed to identify the various urogenital infections, associated risk factors, and profile the bacterial isolates, and assess their antibiotic resistance among women attending Mwingi Hospital.
A cross-sectional study was conducted on 322 women aged between the ages of 15 to 44 years. Urine and high vaginal swabs were collected from all participants and analyzed within 6 hours. Microscopic examination on wet mounts was done, bacterial isolation was done and those with significant growth were confirmed and subjected to antimicrobial susceptibility testing using specific media. Descriptive statistics were used in expressing the infection frequencies and antimicrobial resistance. Odds ratios were used to determine the risk of urogenital infection. The level of significance was considered at a P value of less than 0.05.
Among the 322 women, 45.3% (146) had a urogenital infection, with bacteria being the primary cause (26.4%). The infections included UTI (22.7%), (15.2%), (3.7%), (2.5%), and (1.2%). Antibiotic use was 32.9%, with only 2.8% receiving a microbiological diagnosis before antibiotic use. The overall antibiotic resistance was 53%, with the lowest resistance observed against penicillin and combinations (31.4%) and 3rd Cephalosporins (39.4%). The highest resistance was observed against nalidixic acid (74.8%) and cotrimoxazole (62.6%).
Women attending Mwingi Hospital are commonly affected by various urogenital infections. Antibiotic use without microbiological diagnosis was observed. Among the antibiotics tested, 3 generation cephalosporins and penicillin combination agents were noted as the most effective in treating bacterial urogenital infections, while nalidixic acid and cotrimoxazole were ineffective. Improved diagnosis and targeted treatments are necessary to prevent further development of antibiotic resistance.
泌尿生殖系统感染对公众健康构成了相当大的威胁,因为几乎一半的女性在其一生中的某个阶段会经历泌尿系统和生殖系统感染。然而,在某些地区,泌尿生殖系统感染的负担往往并不明确。尽管如此,包括自行用药在内的抗菌药物滥用增加了广泛的抗菌药物耐药性,限制了治疗效果。因此,本研究旨在确定各种泌尿生殖系统感染、相关危险因素,分析分离出的细菌,并评估在姆温吉医院就诊的女性中这些细菌的抗生素耐药性。
对322名年龄在15至44岁之间的女性进行了一项横断面研究。从所有参与者中采集尿液和高阴道拭子,并在6小时内进行分析。进行了湿片显微镜检查、细菌分离,对生长显著的样本进行确认,并使用特定培养基进行抗菌药物敏感性测试。使用描述性统计来表示感染频率和抗菌药物耐药性。比值比用于确定泌尿生殖系统感染的风险。显著性水平设定为P值小于0.05。
在322名女性中,45.3%(146名)患有泌尿生殖系统感染,细菌是主要病因(26.4%)。感染包括尿路感染(22.7%)、[此处原文缺失部分感染类型名称](15.2%)、[此处原文缺失部分感染类型名称](3.7%)、[此处原文缺失部分感染类型名称](2.5%)和[此处原文缺失部分感染类型名称](1.2%)。抗生素使用率为32.9%,只有2.8%的患者在使用抗生素前接受了微生物学诊断。总体抗生素耐药率为53%,对青霉素及其组合(31.4%)和第三代头孢菌素(39.4%)的耐药率最低。对萘啶酸(74.8%)和复方新诺明(62.6%)的耐药率最高。
在姆温吉医院就诊的女性普遍受到各种泌尿生殖系统感染的影响。观察到存在未进行微生物学诊断就使用抗生素的情况。在所测试的抗生素中,第三代头孢菌素和青霉素联合制剂被认为是治疗细菌性泌尿生殖系统感染最有效的药物,而萘啶酸和复方新诺明则无效。为防止抗生素耐药性的进一步发展,需要改进诊断和进行针对性治疗。